﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2023v5.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2024-10-23T14:13:37-04:00</ReturnTs>
    <TaxPeriodEndDt>2023-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>411326473</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>ALAN C ANDERSON CHARTERED CPA</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>121 14TH STREET NE SUITE B</AddressLine1Txt>
        <CityNm>ROCHESTER</CityNm>
        <StateAbbreviationCd>MN</StateAbbreviationCd>
        <ZIPCd>55906</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2023-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>411996160</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>NORTH AMERICAN SPECIALIZED</BusinessNameLine1Txt>
        <BusinessNameLine2Txt>COAGULATION LABORATORY</BusinessNameLine2Txt>
      </BusinessName>
      <BusinessNameControlTxt>NORT</BusinessNameControlTxt>
      <PhoneNum>5072811468</PhoneNum>
      <USAddress>
        <AddressLine1Txt>121 14TH ST NE STE B</AddressLine1Txt>
        <CityNm>ROCHESTER</CityNm>
        <StateAbbreviationCd>MN</StateAbbreviationCd>
        <ZIPCd>55906</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>KRISTI SMOCK MD</PersonNm>
      <PersonTitleTxt>PRESIDENT</PersonTitleTxt>
      <PhoneNum>5072811468</PhoneNum>
      <SignatureDt>2024-10-22</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>false</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>PHIL PAGEL CPA</PreparerPersonNm>
      <PTIN>P01340408</PTIN>
      <PhoneNum>5072883947</PhoneNum>
      <PreparationDt>2024-10-22</PreparationDt>
    </PreparerPersonGrp>
    <TaxYr>2023</TaxYr>
    <BuildTS>2024-10-15 13:58:12Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="3">
    <IRS990 documentId="RetDoc1" referenceDocumentId="RetDoc2">
      <PrincipalOfficerNm>ELIZABETH A PLUMHOFF MTASCP</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>MAYO CLINIC ROCHESTER</AddressLine1Txt>
        <CityNm>ROCHESTER</CityNm>
        <StateAbbreviationCd>MN</StateAbbreviationCd>
        <ZIPCd>55905</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>399001</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>false</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.NASCOLA.COM</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>2000</FormationYr>
      <LegalDomicileStateCd>MN</LegalDomicileStateCd>
      <ActivityOrMissionDesc>NASCOLA'S PRIMARY MISSION IS TO PROVIDE EXTERNAL QUALITY ASSESSMENT (PROFICIENCY TESTING) FOR TESTS USED TO DIAGNOSE BLEEDING OR PROTHROMBOTIC DISORDERS, THEREBY PROMOTING HIGH STANDARDS OF PERFORMANCE AND PRACTICE FOR SPECIALIZED COAGULATION LABORATORIES IN THE USA, CANADA, MEXICO, CENTRAL AMERICA AND THE CARIBBEAN. OTHER MISSIONS OF NASCOLA INCLUDE PROMOTING EDUCATION FOR PHYSICIANS, LABORATORY TECHNOLOGISTS, AND OTHER HEALTHCARE PROFESSIONALS, ENHANCING COMMUNICATION AMONG LABORATORIES PERFORMING SPECIALIZED COAGULATION TESTING, DEVELOPING GUIDELINES FOR APPROPRIATE USE, PERFORMANCE AND INTERPRETATION OF COAGULATION TESTS AND RESULTS, PROVIDING A FORUM FOR CRITICAL EVALUATION OF EXISTING AND NEW LABORATORY TEST PROCEDURES, INSTRUMENTATION AND REAGENTS, COLLABORATING WITH OTHER NATIONAL AND INTERNATIONAL ORGANIZATIONS FOCUSED ON PROVIDING EXTERNAL QUALITY ASSESSMENT FOR HEMOSTASIS AND THROMBOSIS TESTING, AND SUPPORTING COLLABORATIVE RESEARCH.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>8</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>8</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>0</TotalEmployeeCnt>
      <TotalVolunteersCnt>8</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <CYContributionsGrantsAmt>0</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>313519</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>393613</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>304</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>5388</CYInvestmentIncomeAmt>
      <CYOtherRevenueAmt>0</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>313823</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>399001</CYTotalRevenueAmt>
      <CYGrantsAndSimilarPaidAmt>0</CYGrantsAndSimilarPaidAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>32538</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>32638</CYSalariesCompEmpBnftPaidAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>0</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>253150</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>263822</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>285688</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>296460</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>28135</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>102541</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>778096</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>880637</TotalAssetsEOYAmt>
      <TotalLiabilitiesEOYAmt>0</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>778096</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>880637</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>NASCOLA'S PRIMARY MISSION IS TO PROVIDE EXTERNAL QUALITY ASSESSMENT (PROFICIENCY TESTING) FOR TESTS USED TO DIAGNOSE BLEEDING OR PROTHROMBOTIC DISORDERS, THEREBY PROMOTING HIGH STANDARDS OF PERFORMANCE AND PRACTICE FOR SPECIALIZED COAGULATION LABORATORIES IN THE USA, CANADA, MEXICO, CENTRAL AMERICA AND THE CARIBBEAN. OTHER MISSIONS OF NASCOLA INCLUDE PROMOTING EDUCATION FOR PHYSICIANS, LABORATORY TECHNOLOGISTS, AND OTHER HEALTHCARE PROFESSIONALS, ENHANCING COMMUNICATION AMONG LABORATORIES PERFORMING SPECIALIZED COAGULATION TESTING, DEVELOPING GUIDELINES FOR APPROPRIATE USE, PERFORMANCE AND INTERPRETATION OF COAGULATION TESTS AND RESULTS, PROVIDING A FORUM FOR CRITICAL EVALUATION OF EXISTING AND NEW LABORATORY TEST PROCEDURES, INSTRUMENTATION AND REAGENTS, COLLABORATING WITH OTHER NATIONAL AND INTERNATIONAL ORGANIZATIONS FOCUSED ON PROVIDING EXTERNAL QUALITY ASSESSMENT FOR HEMOSTASIS AND THROMBOSIS TESTING, AND SUPPORTING COLLABORATIVE RESEARCH.</MissionDesc>
      <SignificantNewProgramSrvcInd>false</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>false</SignificantChangeInd>
      <ExpenseAmt>287000</ExpenseAmt>
      <RevenueAmt>393613</RevenueAmt>
      <Desc>PROFICIENCY TESTING IS OFFERED AT LOW COST FOR MANY SPECIAL COAGULATION TESTS(FACTOR DEFICIENCIES, HYPERCOAGULABILITY, ETC) INCLUDING THOSE THAT ARE RARELY ASSESSED BY OTHER PROGRAMS (FACTOR XIII, FACTOR VIII INHIBITOR, FIBRINOLYSIS ASSAYS, INTERPRETATION OF PLATELET AGGREGATION FINDINGS, PLATELET DENSE GRANULE EVALUATION, AND OTHERS).</Desc>
      <TotalProgramServiceExpensesAmt>287000</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc3">true</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd>false</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>false</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>false</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>false</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd>false</DonorAdvisedFundInd>
      <ConservationEasementsInd>false</ConservationEasementsInd>
      <CollectionsOfArtInd>false</CollectionsOfArtInd>
      <CreditCounselingInd>false</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd>false</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd>false</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd>false</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd>false</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd>false</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd>false</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd>false</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd>false</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd>false</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>false</SchoolOperatingInd>
      <ForeignOfficeInd>false</ForeignOfficeInd>
      <ForeignActivitiesInd>false</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>false</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>false</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>false</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>false</FundraisingActivitiesInd>
      <GamingActivitiesInd>false</GamingActivitiesInd>
      <OperateHospitalInd>false</OperateHospitalInd>
      <GrantsToOrganizationsInd>false</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd>false</GrantsToIndividualsInd>
      <ScheduleJRequiredInd>false</ScheduleJRequiredInd>
      <TaxExemptBondsInd>false</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>false</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>false</PYExcessBenefitTransInd>
      <LoanOutstandingInd>false</LoanOutstandingInd>
      <GrantToRelatedPersonInd>false</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>false</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>false</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd>false</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd>false</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>false</DeductibleArtContributionInd>
      <TerminateOperationsInd>false</TerminateOperationsInd>
      <PartialLiquidationInd>false</PartialLiquidationInd>
      <DisregardedEntityInd>false</DisregardedEntityInd>
      <RelatedEntityInd>false</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>false</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>false</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>false</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>false</ScheduleORequiredInd>
      <IRPDocumentCnt>3</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <EmployeeCnt>0</EmployeeCnt>
      <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>false</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>false</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>false</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>false</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>false</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>false</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>false</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>false</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>false</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>false</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>8</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>8</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>false</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>false</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>false</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>false</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>true</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>true</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>true</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>true</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>true</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>false</OfficerMailingAddressInd>
      <LocalChaptersInd>false</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>false</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>false</ConflictOfInterestPolicyInd>
      <WhistleblowerPolicyInd>false</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>false</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>false</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>false</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>false</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>MN</StatesWhereCopyOfReturnIsFldCd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <PersonNm>ELIZABETH PLUMHOFF</PersonNm>
        <PhoneNum>5072811468</PhoneNum>
        <USAddress>
          <AddressLine1Txt>1010 9TH AVE NW</AddressLine1Txt>
          <CityNm>ROCHESTER</CityNm>
          <StateAbbreviationCd>MN</StateAbbreviationCd>
          <ZIPCd>55901</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>ELIZABETH A PLUMHOFF MTASCP</PersonNm>
        <TitleTxt>EXECUTIVE DI</TitleTxt>
        <AverageHoursPerWeekRt>10.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>32638</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JING JIN</PersonNm>
        <TitleTxt>MEMBER-AT-LA</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ANDREW GOODWIN MD</PersonNm>
        <TitleTxt>MEMBER-AT-LA</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KRISTI SMOCK MD</PersonNm>
        <TitleTxt>PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>10.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MARIAN ROLLINS-RAVAL MD</PersonNm>
        <TitleTxt>TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>RAE KERLIN BS MLS ASCP NCA</PersonNm>
        <TitleTxt>MEMBER-AT-LA</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>NICOLE ZANTEK MD PHD</PersonNm>
        <TitleTxt>VICE PRESIDE</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>RICHARD MARLAR PHD</PersonNm>
        <TitleTxt>PAST PRESIDE</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SABRINA RACINE-BRZOSTEK MD PHD</PersonNm>
        <TitleTxt>SECRETARY</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>32638</TotalReportableCompFromOrgAmt>
      <FormerOfcrEmployeesListedInd>false</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>false</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>false</CompensationFromOtherSrcsInd>
      <ProgramServiceRevenueGrp>
        <Desc>MEMBERSHIP / ECAT DUES</Desc>
        <BusinessCd>541700</BusinessCd>
        <TotalRevenueColumnAmt>393613</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>393613</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalProgramServiceRevenueAmt>393613</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>5388</TotalRevenueColumnAmt>
        <ExclusionAmt>5388</ExclusionAmt>
      </InvestmentIncomeGrp>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>399001</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>393613</RelatedOrExemptFuncIncomeAmt>
        <ExclusionAmt>5388</ExclusionAmt>
      </TotalRevenueGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>32638</TotalAmt>
        <ProgramServicesAmt>32638</ProgramServicesAmt>
      </CompCurrentOfcrDirectorsGrp>
      <FeesForServicesManagementGrp>
        <TotalAmt>14382</TotalAmt>
        <ProgramServicesAmt>14382</ProgramServicesAmt>
      </FeesForServicesManagementGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>1165</TotalAmt>
        <ManagementAndGeneralAmt>1165</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <AdvertisingGrp>
        <TotalAmt>225</TotalAmt>
        <ProgramServicesAmt>225</ProgramServicesAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>6553</TotalAmt>
        <ProgramServicesAmt>6000</ProgramServicesAmt>
        <ManagementAndGeneralAmt>553</ManagementAndGeneralAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>7971</TotalAmt>
        <ProgramServicesAmt>3985</ProgramServicesAmt>
        <ManagementAndGeneralAmt>3986</ManagementAndGeneralAmt>
      </InformationTechnologyGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>16176</TotalAmt>
        <ProgramServicesAmt>16176</ProgramServicesAmt>
      </ConferencesMeetingsGrp>
      <InsuranceGrp>
        <TotalAmt>4808</TotalAmt>
        <ProgramServicesAmt>2404</ProgramServicesAmt>
        <ManagementAndGeneralAmt>2404</ManagementAndGeneralAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>ECAT FEES</Desc>
        <TotalAmt>208178</TotalAmt>
        <ProgramServicesAmt>208178</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>DONATIONS</Desc>
        <TotalAmt>1684</TotalAmt>
        <ProgramServicesAmt>1684</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>REIMBURSEMENTS</Desc>
        <TotalAmt>1328</TotalAmt>
        <ProgramServicesAmt>1328</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>BANK CHARGES</Desc>
        <TotalAmt>1002</TotalAmt>
        <ManagementAndGeneralAmt>1002</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>350</TotalAmt>
        <ManagementAndGeneralAmt>350</ManagementAndGeneralAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>296460</TotalAmt>
        <ProgramServicesAmt>287000</ProgramServicesAmt>
        <ManagementAndGeneralAmt>9460</ManagementAndGeneralAmt>
        <FundraisingAmt>0</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>569374</BOYAmt>
        <EOYAmt>535785</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>208722</BOYAmt>
        <EOYAmt>344852</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <TotalAssetsGrp>
        <BOYAmt>778096</BOYAmt>
        <EOYAmt>880637</EOYAmt>
      </TotalAssetsGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>778096</BOYAmt>
        <EOYAmt>880637</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>778096</BOYAmt>
        <EOYAmt>880637</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>778096</BOYAmt>
        <EOYAmt>880637</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>102541</ReconcilationRevenueExpnssAmt>
      <MethodOfAccountingCashInd>X</MethodOfAccountingCashInd>
      <AccountantCompileOrReviewInd>false</AccountantCompileOrReviewInd>
      <FSAuditedInd>false</FSAuditedInd>
      <FederalGrantAuditRequiredInd>false</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc3">
      <PubliclySupportedOrg509a2Ind>X</PubliclySupportedOrg509a2Ind>
      <GrossReceiptsAdmissionsGrp>
        <CurrentTaxYearMinus4YearsAmt>310429</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>294663</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>470640</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>313519</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>393613</CurrentTaxYearAmt>
        <TotalAmt>1782864</TotalAmt>
      </GrossReceiptsAdmissionsGrp>
      <Total509Grp>
        <CurrentTaxYearMinus4YearsAmt>310429</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>294663</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>470640</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>313519</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>393613</CurrentTaxYearAmt>
        <TotalAmt>1782864</TotalAmt>
      </Total509Grp>
      <PublicSupportTotal509Amt>1782864</PublicSupportTotal509Amt>
      <GrossInvestmentIncome509Grp>
        <CurrentTaxYearMinus4YearsAmt>358</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>51</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>20</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>304</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>5388</CurrentTaxYearAmt>
        <TotalAmt>6121</TotalAmt>
      </GrossInvestmentIncome509Grp>
      <InvestmentIncomeAndUBTIGrp>
        <CurrentTaxYearMinus4YearsAmt>358</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>51</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>20</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>304</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>5388</CurrentTaxYearAmt>
        <TotalAmt>6121</TotalAmt>
      </InvestmentIncomeAndUBTIGrp>
      <TotalSupportCalendarYearGrp>
        <CurrentTaxYearMinus4YearsAmt>310787</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>294714</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>470660</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>313823</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>399001</CurrentTaxYearAmt>
        <TotalAmt>1788985</TotalAmt>
      </TotalSupportCalendarYearGrp>
      <PublicSupportCY509Pct>0.99660</PublicSupportCY509Pct>
      <PublicSupportPY509Pct>0.99950</PublicSupportPY509Pct>
      <InvestmentIncomeCYPct>0.00000</InvestmentIncomeCYPct>
      <InvestmentIncomePYPct>0.00000</InvestmentIncomePYPct>
      <ThirtyThrPctSuprtTestsCY509Ind>X</ThirtyThrPctSuprtTestsCY509Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleO documentId="RetDoc2">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990 - ORGANIZATION'S MISSION</FormAndLineReferenceDesc>
        <ExplanationTxt>NASCOLA'S PRIMARY MISSION IS TO PROVIDE EXTERNAL QUALITY ASSESSMENT (PROFICIENCY TESTING) FOR TESTS USED TO DIAGNOSE BLEEDING OR PROTHROMBOTIC DISORDERS, THEREBY PROMOTING HIGH STANDARDS OF PERFORMANCE AND PRACTICE FOR SPECIALIZED COAGULATION LABORATORIES IN THE USA, CANADA, MEXICO, CENTRAL AMERICA AND THE CARIBBEAN. OTHER MISSIONS OF NASCOLA INCLUDE PROMOTING EDUCATION FOR PHYSICIANS, LABORATORY TECHNOLOGISTS, AND OTHER HEALTHCARE PROFESSIONALS, ENHANCING COMMUNICATION AMONG LABORATORIES PERFORMING SPECIALIZED COAGULATION TESTING, DEVELOPING GUIDELINES FOR APPROPRIATE USE, PERFORMANCE AND INTERPRETATION OF COAGULATION TESTS AND RESULTS, PROVIDING A FORUM FOR CRITICAL EVALUATION OF EXISTING AND NEW LABORATORY TEST PROCEDURES, INSTRUMENTATION AND REAGENTS, COLLABORATING WITH OTHER NATIONAL AND INTERNATIONAL ORGANIZATIONS FOCUSED ON PROVIDING EXTERNAL QUALITY ASSESSMENT FOR HEMOSTASIS AND THROMBOSIS TESTING, AND SUPPORTING COLLABORATIVE RESEARCH.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 6</FormAndLineReferenceDesc>
        <ExplanationTxt>NASCOLA WELCOMES MEMBERSHIP AT VARIOUS LEVELS OF PARTICIPATION: INSTITUTION MEMBER, ASSOCIATE (CORPORATE) MEMBER, AND INDIVIDUAL MEMBER. INSTITUTION AND ASSOCIATE MEMBERS MAY CHOOSE WHETHER OR NOT THEY WISH TO PARTICIPATE IN THE PROFICIENCY TESTING PROGRAM.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 7A</FormAndLineReferenceDesc>
        <ExplanationTxt>MEMBERS PARTICIPATE IN ELECTION OF THE MEMBERS OF THE EXECUTIVE COMMITTEE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 7B</FormAndLineReferenceDesc>
        <ExplanationTxt>GOVERNANCE DECISIONS ARE SUBJECT TO THE APPROVAL OF MEMBERS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>NO REVIEW WAS OR WILL BE CONDUCTED.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>GOVERNING DOCUMENTS WILL BE MADE AVAILABLE UPON REQUEST, SUBJECT TO APPROVAL BY THE EXECUTIVE COMMITTEE.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>